syndrome, who have recurrent ICD shocks secondary to refractory VT.

2. Substrate-based ablation can be performed in both ARVD and Brugada syndrome, without the need to induce unstable VT in the EP lab.

3. Epicardial ablation, along with endocardial ablation, is frequently required in both these entities.

3. In Brugada syndrome, sodium channel blocker (procainamide/ flecainide) can be used to unmask abnormal areas in some patients.

4. Triggering PVCs, if present in the EP lab, can be targeted for ablation.